News

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...
A federal appeals court on Wednesday revived part of a lawsuit accusing the Federal Reserve Bank of New York of illegally ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.
Karnataka CM Siddaramaiah’s claim linking COVID-19 vaccines to a spike in heart attack deaths in Hassan district has been ...